Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases

Randi J Bertelsen1, Anne Lise Brantsæter2, Maria C Magnus3

  • 1Department of Food, Water and Cosmetics, Norwegian Institute of Public Health, Oslo, Norway; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC.

Insights

Probiotic milk consumption during pregnancy and infancy may reduce the risk of infant eczema and rhinoconjunctivitis. However, it did not show an association with asthma development by age 36 months.

Area of Science:

  • Microbiome research
  • Pediatric allergy and immunology
  • Public health and epidemiology

Background:

  • The role of probiotics in influencing the infant microbiome and preventing allergic diseases is not fully understood.
  • Previous studies on probiotics for infant allergies primarily focused on high-risk infants.

Purpose of the Study:

  • To investigate the association between probiotic milk product consumption and the incidence of atopic eczema, rhinoconjunctivitis, and asthma in early childhood.
  • Utilized a large, population-based pregnancy cohort in Norway for this investigation.

Main Methods:

  • Examined data from 40,614 children within the Norwegian Mother and Child Cohort study.
  • Assessed correlations between maternal probiotic milk intake during pregnancy and infant intake with reported allergic outcomes.
  • Employed general linear models to calculate relative risks (RRs), adjusting for potential confounding factors.

Main Results:

  • Maternal probiotic milk consumption during pregnancy was linked to a reduced risk of atopic eczema at 6 months (adjusted RR, 0.94) and rhinoconjunctivitis between 18-36 months (adjusted RR, 0.87).
  • Combined maternal and infant probiotic milk consumption showed a stronger association with reduced rhinoconjunctivitis risk (adjusted RR, 0.80).
  • No significant association was found between probiotic milk consumption and asthma incidence by 36 months of age.

Conclusions:

  • Consumption of probiotic milk products in a general population cohort was associated with lower incidence of atopic eczema and rhinoconjunctivitis.
  • Probiotic milk consumption did not demonstrate a significant association with the incidence of asthma by 36 months of age.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...